Found: 15
Select item for more details and to access through your institution.
Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach.
- Published in:
- Oncogene, 2007, v. 26, n. 31, p. 4600, doi. 10.1038/sj.onc.1210242
- By:
- Publication type:
- Article
Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
- Published in:
- Journal of Pathology, 2007, v. 212, n. 3, p. 287, doi. 10.1002/path.2165
- By:
- Publication type:
- Article
Knockdown of the epidermal growth factor receptor gene to investigate its therapeutic potential for the treatment of non-small-cell lung cancers.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4427, doi. 10.1038/onc.2012.446
- By:
- Publication type:
- Article
Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer.
- Published in:
- 1998
- By:
- Publication type:
- journal article
A clinicopathological study of synchronous multiple gastric cancer.
- Published in:
- British Journal of Surgery, 1989, v. 76, n. 3, p. 237, doi. 10.1002/bjs.1800760308
- By:
- Publication type:
- Article
F-082SIGNIFICANCE OF SERUM CARCINOEMBRYONIC ANTIGEN AT THE FOLLOW-UP OF COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2013, v. 17, n. suppl_1, p. S1, doi. 10.1093/icvts/ivt288.82
- By:
- Publication type:
- Article
Short communications. Frameshift mutations in TGFβRII, IGFIIR, BAX, hMSH3 and hMSH6 are absent in lung cancers.
- Published in:
- Carcinogenesis, 1999, v. 20, n. 3, p. 499, doi. 10.1093/carcin/20.3.499
- By:
- Publication type:
- Article
A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204).
- Published in:
- 2008
- By:
- Publication type:
- journal article
A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib.
- Published in:
- British Journal of Cancer, 2007, v. 96, n. 8, p. 1191, doi. 10.1038/sj.bjc.6603710
- By:
- Publication type:
- Article
Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?
- Published in:
- British Journal of Cancer, 2007, v. 96, n. 6, p. 857, doi. 10.1038/sj.bjc.6603665
- By:
- Publication type:
- Article
Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas.
- Published in:
- British Journal of Cancer, 2001, v. 84, n. 9, p. 1199, doi. 10.1054/bjoc.2001.1722
- By:
- Publication type:
- Article